Research
Our work is dedicated to advancing mitochondrial genome editing technologies to treat mitochondrial diseases. This comprehensive strategy includes developing therapeutic methods in genome and cell therapy and deeply exploring mitochondrial genomics and genetics.
Topics
Development
Our research is dedicated to innovating and enhancing mitochondrial genome editing technologies. We focus on reducing off-target effects and increasing precision to advance the field of mitochondrial genome editing.
Application
We utilize mitochondrial editing technology in cells and artificial organs to simulate mitochondrial diseases. We also generate and analyze animal models for mitochondrial diseases.
Therapeutic
We are advancing the development of mitochondrial genome editing treatments. Our focus encompasses both genome therapy and cell therapy, aiming to offer effective solutions for these conditions.
Investigation
Using mitochondrial editing technology, we are studying the functions of mitochondrial genes and the correlations between mutations and phenotypes. Furthermore, we are exploring the mechanisms of complex mitochondrial genetics.
